1 year return (CAGR)
-25.27%
Lexeo Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
LXEO
3.31
-0.12 (-2.86%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
334.75M
Price/Sales
-
Ent value
261.75M
Price/Book
1.42
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.24 |
| Daily high | 4.33 |
| Daily low | 4.04 |
| Daily Volume | 855K |
| All-time high | 18.76 |
| 1y analyst estimate | 20.30 |
| Beta | 1.47 |
| EPS (TTM) | -1.02 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 16 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LXEO | S&P500 | |
| Current price drop from All-time high | -82.36% | -0.84% |
| Highest price drop | -90.46% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -52.91% | -10.68% |
| Avg time to new high | 38 days | 12 days |
| Max time to new high | 569 days | 1805 days |
News
